Article Information
History
- August 23, 2024.
Article Versions
- You are currently viewing Version 1 of this article (August 23, 2024 - 16:43).
- Version 2 (August 26, 2024 - 13:49).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Dimitrios Tsallos1,
- Nemo Ikonen1,
- Juho J. Miettinen1,
- Muntasir Mamun Majumder1,
- Samuli Eldfors1,2,
- Imre Västrik1,
- Alun Parsons1,
- Minna Suvela1,
- Katie Dunphy3,
- Paul Dowling3,
- Despina Bazou4,
- Peter O’Gorman5,
- Juha Lievonen6,
- Raija Silvennoinen6,
- Pekka Anttila6 and
- Caroline A. Heckman1,*
- 1Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, University of Helsinki, iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland;
- 2Massachusetts General Hospital Cancer Center, Charlestown, MA, and Department of Medicine, Harvard Medical School, Boston, MA, USA;
- 3Department of Biology, Maynooth University, W23 F2K8, Maynooth, Ireland;
- 4School of Medicine, University College Dublin, D04 V1W8 Dublin, Ireland;
- 5Department of Haematology, Mater Misericordiae University Hospital, D07 WKW8, Dublin, Ireland;
- 6Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, University of Helsinki, Helsinki, Finland
- ↵*Corresponding author:
Caroline A. Heckman, PhD, Institute for Molecular Medicine Finland – FIMM University of Helsinki, Tukholmankatu 8 (P.O. Box 20) FI-00290 Helsinki, Finland, c: +358 50 4156769, caroline.heckman{at}helsinki.fi